Abstract
This study explores the differential effect of a managed behavioral health Carve-Out (CO) on outpatient treatment quality for persons with schizophrenia (SCHZ) alone and co-occurring substance use disorders (SUD) (SCHZ+SUD). We used claims data from a state Medicaid program and employed a retrospective, quasi-experimental design with logit and difference in difference formula regression models. The results show the CO was associated with greater changes in treatment quality for the SCHZ population, compared to the SCHZ+SUD population. Most pronounced across both populations were decrements in receiving the psychosocial treatments for enrollees in the CO arrangement.
Similar content being viewed by others
References
Alterman, A. I., Erdlen, D. L., & Murphy, E. (1982) Effects of illicit drug use in an inpatient psychiatric population. Addictive Disorders, 7, 231–242
Barbee, J. G., Clark, P. D., Crapanzano, M. S., Heintz, G. C., & Kehoe, C. E. (1989) Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. Journal of Nervous and Mental Disease, 177, 400–407
Bartels, S. J., Drake, R. E., & Wallach, M. A. (1995) Long term course of substance use disorders among patients with severe mental illness. Psychiatric Services, 46(3), 248–251
Bloom, J. R., Hu, T.-W., Wallace, N., Cuffel, B., Hausman, J. W., Sheu, M.-L., & Scheffler, R. (2002) Mental health costs and access under alternative capitation systems in Colorado. Health Services Research, 37(2), 315–340
Busch, A. B., Frank, R. G., & Lehman, A. F. (2004) The effect of a managed behavioral health carve-out on quality of care for Medicaid patients diagnosed as having schizophrenia. Archives of General Psychiatry, 61(5), 442–448
Carpenter, W. T. J., Heinrichs, D. W., & Alphs L. D. (1985) Treatment of negative symptoms. Schizophrenia Bulletin, 11, 440–452
Cohen, L. J., Test, M. A., & Brown, R. L. (1990) Suicide and schizophrenia: Data from a prospective community treatment study. American Journal of Psychiatry, 147(5), 602–607
Cuffel, B. J., Bloom, J. R., Wallace, N., Hausman, J. W., & Hu, T.-W. (2002) Two-year outcomes of fee-for-service and capitated Medicaid programs for people with severe mental illness. Health Services Research, 37(2), 341–359
Dickey, B., Normand, S.-L. T., Hermann, R. C., Eisen, S. V., Cortes, D. E., Cleary, P. D., & Ware, N. (2003) Guideline recommendations for treatment of schizophrenia. Archives of General Psychiatry, 60(4), 340–348
Drake, R. E., & Wallach, M. A. (1989) Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry, 40, 1041–1046
Farris, C., Brems, C., Johnson, M. E., Wells, R., Burns, R., & Kletti, N. (2003) A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatric Quarterly, 74(3), 205–222
Frank, R. G., & McGuire, T. G. (1998). The economic functions of carve-outs in managed care. American Journal of Managed Care, 4(SP):SP31–SP39
Frank, R. G., & McGuire, T. G. (2000) Economics and mental health. In: Culyer, A., Newhouse, J. (Eds.), Handbook of health economics (pp. 893–954). Amsterdam, Elsevier
Hays, P., & Aidroos, N. (1986) Alcoholism followed by schizophrenia. Acta Psychiatrica Scandinavica, 74(2), 187–189
Hunt, G. E., Bergen, J., & Bashir, M. (2002) Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival 4 years after a relapse. Schizophrenia Research, 54, 253–264
Kirchner, J. E., Owen, R. R., Nordquist, C., & Fischer, E. P. (1998) Diagnosis and management of substance use disorders among inpatients with schizophrenia. Psychiatric Services, 49(1):82–85
Landmark, J., Cernovsky, Z. Z., & Merskey, H. (1987) Correlates of suicide attempts and ideation in schizophrenia. British Journal of Psychiatry, 151, 18–20
Lehman, A. F., Steinwachs, D. M., & the Co-Investigators of the PORT Project (1998). Translating research into practice: The schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophrenia Bulletin 24(1), 1–10
Linszen, D. H. M. D., Dingemans, P. M., & Lenior, M. E. (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51(4), 273–279
Lurie, N., Popkin, M., Dysken, M., Moscovice, I., & Finch, M. (1992). Accuracy of diagnoses of schizophrenia in Medicaid claims. Hospital and Community Psychiatry, 43(1), 69–71
Mark, T., Coffey, R. M. M. D., Harwood, H., King, E., Bouchery, E., Genuardi, J., Vandivort, R., Buck, J.A., & Dilonardo, J. (2005). National expenditures for mental health services and substance abuse treatment: 1991–2001 (pp. 1–69), U.S. Department of Health and Human Services: Substance Abuse and Mental Health Services Administration
Mechanic, D., & McAlpine, D. D. (2000) Utilization of specialty mental health care among persons with severe mental illness: The roles of demographics, need, insurance and risk. Health Services Research, 35(1), 277–292
Negrete, J. C., Knapp, W. P., Douglas, D. E., & Smith, W. B. (1986) Cannabis affects the severity of schizophrenia symptoms: Results of a clinical survey. Psychological Medicine, 16, 515–520
Ray, W. A., Daugherty, J. R., & Meador, K. C. (2003) Effect of a mental health “carve-out” program on the continuity of antipsychotic therapy. The New England Journal of Medicine, 348(19), 1885–1894
Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511–2518
Shern, D. L., Robinson, P., Stiles P., et al (2000) Evaluation of Florida’s prepaid mental health plan Year 3 report. University of South Florida, Tampa
Shern, D. L., Giard, J., Robinson, P., Stiles, P., Boothroyd, R., Murrin, M. R., Chen, H., Boaz, T., Dow, M., & Ward, J. (2001). Evaluation of Florida’s prepaid mental health plan: Year 4 report. Tampa: Louis de la Parte Florida Mental Health Institute, University of South Florida
Sokolski, K. N., Cummings, J. L., Abrams, B. O., MeMet, E. M., Katz, L. S., & Costa, J. F. (1994) Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients. Journal of Clinical Psychiatry, 55, 380–387
Substance Abuse and Mental Health Services Administration (1999). SAMHSA managed care initiative state profiles: Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration (2002). Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. U.S. Department of Health and Human Services, Washington, D.C.
Suominen, K. H., Isometsae, E. T., & Loennqvist, J. K. (2002) Comorbid substance use reduces the health care contacts of suicide attempters with schizophrenia spectrum or mood disorders. Schizophrenia Bulletin, 28(4), 637–647
Young, A. S., Klap, R., Sherbourne, C. D., & Wells, K. B. (2001) The quality of care for depressive and anxiety disorders in the United States. Archives of General Psychiatry, 58(1), 55–61
Zeger, S. L., & Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121–130
Acknowledgements
We gratefully acknowledge funding from the NIMH (R01MH62028, R01MH62028: Drs. Busch and Frank; and R01MH59254: Dr. Frank), NIDA (K08 DA00407: Dr. Greenfield; 2 P50 DA10233-06A2: Drs. Frank and Greenfield), the McLean Hospital Maria Lorenz-Pope Award (Dr. Busch) and the National Center on Minority Health and Health Disparities (Dr. Busch). The funding organizations had no role in the collection, analysis or interpretation of the data. They also had no role in the preparation, review or approval of this manuscript. We also thank Christina Fu, Ph.D. for her programming expertise on this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
An earlier version of this analysis was presented on June 24, 2004 at the Co-occurring Conditions Conference sponsored by NIMH, NIDA, NIAAA, AHRQ, HRSA AND SAMHSA.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Busch, A.B., Frank, R.G., Lehman, A.F. et al. Schizophrenia, Co-occurring Substance use Disorders and Quality of Care: The Differential Effect of a Managed Behavioral Health Care Carve-out. Adm Policy Ment Health 33, 388–397 (2006). https://doi.org/10.1007/s10488-006-0045-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10488-006-0045-3